# Immuno−oncological effects of aerobic exercise combined with anti−PD−L1 antibody blockade in a murine breast cancer model

**Authors:** Amirhossein Ahmadi Hekmatikar, Hamid Agha-Alinejad, Aliakbar Yousefi-Ahmadipour, Mahdieh Molanouri Shamsi, D. Maryama Awang Daud

PMC · DOI: 10.3389/fonc.2026.1671244 · Frontiers in Oncology · 2026-01-27

## TL;DR

This study shows that combining aerobic exercise with anti-PD-L1 treatment in mice reduces tumor size and boosts immune cell activity against breast cancer.

## Contribution

The study demonstrates a novel combination of aerobic exercise and anti-PD-L1 therapy enhancing anti-tumor immunity in a murine model.

## Key findings

- Mice receiving combined exercise and anti-PD-L1 therapy had higher CD4+ and CD8+ T cell infiltration in tumors.
- The combination treatment led to significantly smaller tumor volumes compared to the control group.
- Exercise alone showed similar but less pronounced effects on immune cell density and tumor size.

## Abstract

Immunotherapy has emerged as a crucial approach in cancer treatment, particularly through targeting immune checkpoints such as programmed cell death protein 1 (PD−1) and its ligand programmed cell death 1 ligand 1 (PD−L1). Blocking antibodies against PD−1/PD−L1 have demonstrated the potential to activate tumor−specific immune cells, particularly CD4+ and CD8+ T cells. Recently, research in exercise oncology has underscored the role of physical activity in augmenting immune function in cancer settings. This study explored the combined impact of aerobic exercise and anti−PD−L1 antibody administration on immunological and physiological responses in a murine breast cancer model. Materials and Methods: Thirty female BALB/c mice were divided into five experimental groups: Patient control group (n=6), Exercise+induction+ control (n=6), Exercise+induction+exercise (n=6), Exercise+induction+anti-PD-L1 (n=6), and Exercise induction exercise + anti-PD−L1 (n=6). After a treadmill acclimation period, mice underwent two 6-week initial training protocols, followed by an additional 4-week protocol post-tumor induction. Following tumor induction, the PD−L1anti−PD−L1 antibody was administered. One-way analysis of variance (ANOVA) was applied to evaluate experimental variables. Results: Statistical analyses showed that, relative to the PCG, mice receiving the combined intervention of EIE and EIE + A displayed higher intratumoral CD4+ and CD8+ T cell densities and smaller final tumor volumes. Similar but less pronounced trends were observed in the EIE and EIE+A. Conclusion: Within the limits of the current design, the combination of aerobic exercise with PD−L1 immune checkpoint blockade was associated with increased tumor−infiltrating CD4+ and CD8+ T−cell density and reduced tumor burden. These findings suggest a potential interaction that warrants evaluation in future studies incorporating a PD−L1−monotherapy group to clarify independent and combined effects.

## Linked entities

- **Proteins:** PDCD1 (programmed cell death 1), CD274 (CD274 molecule), CD4 (CD4 molecule), CD8A (CD8 subunit alpha)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Genes:** Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Pdcd1 (programmed cell death 1) [NCBI Gene 18566] {aka Ly101, PD-1, Pdc1}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}
- **Diseases:** cancer (MESH:D009369), breast cancer (MESH:D001943)
- **Chemicals:** EIE (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12888218/full.md

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12888218/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12888218/full.md

---
Source: https://tomesphere.com/paper/PMC12888218